| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $141,096 | 5 | 100 |
Sells | $0 | 0 | 0 |
| te Boekhorst Paul Francis Olivier | President and CEO | 4 | $125,541 | 0 | $0 | $125,541 |
| Tomsche David Scott | director | 1 | $15,554 | 0 | $0 | $15,554 |
ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U.S. domestic market and international regions. Among its key products is First Defense, an orally administered preventative designed to combat scours in newborn dairy and beef calves. The company also provides Tri-Shield First Defense, a passive antibody treatment effective against E. coli, coronavirus, and rotavirus. …
Over the last 12 months, insiders at ImmuCell Corporation have bought $141,096 and sold $0 worth of ImmuCell Corporation stock.
On average, over the past 5 years, insiders at ImmuCell Corporation have bought $51,805 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: te Boekhorst Paul Francis Olivier (President and CEO) — $125,541. Tomsche David Scott (director) — $15,554.
The last purchase of 8,000 shares for transaction amount of $75,960 was made by te Boekhorst Paul Francis Olivier (President and CEO) on 2026‑06‑18.
| 2026-06-18 | te Boekhorst Paul Francis Olivier | President and CEO | 8,000 0.0885% | $9.49 | $75,960 | +6.74% | ||
| 2025-12-04 | te Boekhorst Paul Francis Olivier | President and CEO | 2,432 0.0284% | $5.50 | $13,376 | +82.92% | ||
| 2025-12-03 | te Boekhorst Paul Francis Olivier | President and CEO | 3,598 0.0382% | $5.04 | $18,152 | +81.14% | ||
| 2025-12-02 | te Boekhorst Paul Francis Olivier | President and CEO | 3,708 0.0399% | $4.87 | $18,053 | +89.80% | ||
| 2025-11-25 | Tomsche David Scott | director | 3,266 0.0367% | $4.76 | $15,554 | +100.43% | ||
| 2025-06-12 | Gathagan Bryan K. | director | 1,000 0.0109% | $6.32 | $6,320 | -0.16% | ||
| 2022-06-13 | Cunningham David | 1,000 0.0134% | $8.00 | $8,000 | -5.19% | |||
| 2020-03-12 | Cunningham David | director | 2,000 0.0259% | $4.00 | $8,000 | +40.70% | ||
| 2020-03-11 | Tomsche David Scott | director | 4,600 0.0591% | $4.28 | $19,688 | +30.00% | ||
| 2020-02-27 | Tomsche David Scott | director | 5,130 0.0677% | $4.98 | $25,547 | +12.94% | ||
| 2018-08-16 | Tomsche David Scott | director | 3,000 0.0387% | $6.67 | $20,010 | +4.04% | ||
| 2017-07-27 | PESSIN NORMAN H | 170,000 1.7068% | $5.25 | $892,500 | +6.81% | |||
| 2017-07-27 | Pessin Brian L. | 30,000 0.3012% | $5.25 | $157,500 | +6.81% | |||
| 2017-03-14 | Tomsche David Scott | director | 1,197 0.0155% | $5.44 | $6,510 | +29.89% | ||
| 2017-03-13 | Tomsche David Scott | director | 803 0.0103% | $5.42 | $4,352 | +28.81% | ||
| 2016-11-07 | Tomsche David Scott | director | 4,000 0.0529% | $5.19 | $20,760 | +19.77% | ||
| 2016-08-22 | Cunningham David | director | 3,000 0.0384% | $7.14 | $21,431 | -15.97% | ||
| 2016-07-08 | Sale | CRABB JOSEPH H | VP & Chief Scientific Officer | 1,935 0.0242% | $6.55 | $12,669 | -10.22% | |
| 2016-07-07 | Sale | CRABB JOSEPH H | VP & Chief Scientific Officer | 265 0.0035% | $6.54 | $1,732 | -6.14% | |
| 2016-07-06 | Sale | CRABB JOSEPH H | VP & Chief Scientific Officer | 2,426 0.0313% | $6.59 | $15,979 | -7.85% |
| Tomsche David Scott | director | 52720 0.5805% | $540,380.00 | 29 | 0 | +13.65% |
| te Boekhorst Paul Francis Olivier | President and CEO | 17785 0.1958% | $182,296.25 | 4 | 0 | |
| ROTHSCHILD JONATHAN E | 510158 5.6171% | $5.23M | 107 | 0 | +21.26% | |
| PESSIN NORMAN H | 170000 1.8718% | $1.74M | 1 | 0 | +6.81% | |
| BRIGHAM MICHAEL F | President & CEO | 154870 1.7052% | $1.59M | 5 | 0 | |
| CRABB JOSEPH H | VP & Chief Scientific Officer | 105111 1.1573% | $1.08M | 5 | 5 | |
| Pessin Brian L. | 70000 0.7707% | $717,500.00 | 1 | 0 | +6.81% | |
| Cunningham David | 16000 0.1762% | $164,000.00 | 8 | 0 | +8.25% | |
| Rhodes Linda | director | 7157 0.0788% | $73,359.25 | 10 | 0 | +13.46% |
| Wainman Paul R | director | 2000 0.022% | $20,500.00 | 7 | 0 | +1.37% |
| Bruce Robert C | director | 1000 0.011% | $10,250.00 | 1 | 0 | |
| Gathagan Bryan K. | director | 1000 0.011% | $10,250.00 | 1 | 0 | <0.0001% |
$5,552,811 | 165 | 5.84% | $106.2M | |
ImmuCell Corporation (ICCC) | $1,701,941 | 56 | 17.58% | $93.09M |
$66,137,559 | 49 | 6.29% | $89.66M | |
$77,146,704 | 43 | 13.28% | $93.12M | |
$26,786,140 | 22 | -18.62% | $78.7M |
| Increased Positions | 11 | +40.74% | 92,055 | +7.17% |
| Decreased Positions | 9 | -33.33% | 96,024 | -7.48% |
| New Positions | 2 | New | 980 | New |
| Sold Out Positions | 3 | Sold Out | 178 | Sold Out |
| Total Postitions | 29 | +7.41% | 1M | -0.31% |
| Vanguard Group Inc | $1,828.00 | 3.43% | 308,702 | 0 | 0% | 2025-09-30 |
| Renaissance Technologies Llc | $931.00 | 1.75% | 157,289 | -2,700 | -1.69% | 2025-09-30 |
| Cresset Asset Management, Llc | $781.00 | 1.47% | 132,001 | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $622.00 | 1.17% | 105,116 | +200 | +0.19% | 2025-09-30 |
| Bleichroeder Lp | $601.00 | 1.13% | 101,594 | 0 | 0% | 2025-09-30 |
| Dauntless Investment Group, Llc | $516.00 | 0.97% | 87,121 | -7,573 | -8% | 2025-09-30 |
| Geode Capital Management, Llc | $427.00 | 0.8% | 72,179 | +327 | +0.46% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $369.00 | 0.69% | 62,305 | -7,648 | -10.93% | 2025-09-30 |
| Shufro Rose & Co Llc | $361.00 | 0.68% | 61,028 | 0 | 0% | 2025-09-30 |
| Northern Trust Corp | $224.00 | 0.42% | 37,794 | -4,727 | -11.12% | 2025-09-30 |